Ajit Johnson Nirmal, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tumor Microenvironment | 4 | 2024 | 3810 | 0.390 |
Why?
|
Lymphoma, T-Cell | 2 | 2024 | 305 | 0.360 |
Why?
|
Melanoma | 3 | 2023 | 5692 | 0.320 |
Why?
|
Ecosystem | 2 | 2023 | 488 | 0.310 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5796 | 0.260 |
Why?
|
Factor VIII | 2 | 2018 | 349 | 0.240 |
Why?
|
Depsipeptides | 1 | 2024 | 95 | 0.230 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9374 | 0.220 |
Why?
|
Computer Graphics | 1 | 2022 | 341 | 0.180 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 231 | 0.180 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2347 | 0.180 |
Why?
|
Trachoma | 1 | 2018 | 18 | 0.160 |
Why?
|
Oncogenes | 1 | 2023 | 1221 | 0.150 |
Why?
|
Kupffer Cells | 1 | 2017 | 143 | 0.140 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2017 | 186 | 0.140 |
Why?
|
Drug Discovery | 1 | 2022 | 1054 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2023 | 2911 | 0.120 |
Why?
|
Fetal Growth Retardation | 1 | 2017 | 578 | 0.110 |
Why?
|
Zinc Fingers | 1 | 2015 | 568 | 0.110 |
Why?
|
Neoplasms | 5 | 2024 | 22019 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 652 | 0.110 |
Why?
|
Endonucleases | 1 | 2015 | 370 | 0.110 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2018 | 497 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1588 | 0.100 |
Why?
|
Software | 2 | 2024 | 4421 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1889 | 0.100 |
Why?
|
Fatty Liver | 1 | 2017 | 777 | 0.100 |
Why?
|
Genetic Markers | 1 | 2017 | 2608 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1902 | 0.080 |
Why?
|
Psoriasis | 1 | 2017 | 933 | 0.080 |
Why?
|
Skin | 2 | 2024 | 4467 | 0.080 |
Why?
|
Adiposity | 1 | 2017 | 1848 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1630 | 0.070 |
Why?
|
Cytokines | 1 | 2022 | 7346 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5214 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8929 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5131 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11653 | 0.050 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 191 | 0.050 |
Why?
|
Isoquinolines | 1 | 2024 | 353 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7514 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10440 | 0.050 |
Why?
|
Maximum Tolerated Dose | 1 | 2024 | 876 | 0.050 |
Why?
|
Computational Biology | 2 | 2024 | 3505 | 0.050 |
Why?
|
Purines | 1 | 2024 | 601 | 0.050 |
Why?
|
Drug Eruptions | 1 | 2024 | 335 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20031 | 0.040 |
Why?
|
Humans | 14 | 2024 | 759255 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13621 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2024 | 2474 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11908 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13238 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2022 | 1090 | 0.040 |
Why?
|
Microscopy | 1 | 2022 | 880 | 0.040 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 114 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1756 | 0.040 |
Why?
|
Ubiquitination | 1 | 2022 | 1009 | 0.040 |
Why?
|
Sebaceous Glands | 1 | 2017 | 42 | 0.040 |
Why?
|
Apocrine Glands | 1 | 2017 | 32 | 0.040 |
Why?
|
Sweat Glands | 1 | 2017 | 33 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 998 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2022 | 943 | 0.030 |
Why?
|
Thalidomide | 1 | 2022 | 884 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12580 | 0.030 |
Why?
|
Sus scrofa | 1 | 2017 | 432 | 0.030 |
Why?
|
Hair Follicle | 1 | 2017 | 211 | 0.030 |
Why?
|
K562 Cells | 1 | 2015 | 641 | 0.030 |
Why?
|
Melanocytes | 1 | 2017 | 511 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 2804 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2018 | 1552 | 0.030 |
Why?
|
Dogs | 1 | 2018 | 3838 | 0.030 |
Why?
|
Keratinocytes | 1 | 2017 | 792 | 0.030 |
Why?
|
Cell Survival | 1 | 2022 | 5796 | 0.030 |
Why?
|
Gene Targeting | 1 | 2015 | 839 | 0.030 |
Why?
|
Transgenes | 1 | 2015 | 1006 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2017 | 2675 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18110 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2297 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2015 | 1204 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8540 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 2424 | 0.020 |
Why?
|
Dexamethasone | 1 | 2017 | 1927 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2698 | 0.020 |
Why?
|
Birth Weight | 1 | 2017 | 2091 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4545 | 0.020 |
Why?
|
Animals | 4 | 2023 | 167838 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3774 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6542 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3526 | 0.020 |
Why?
|
Immunotherapy | 1 | 2023 | 4622 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6053 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8157 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81138 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2015 | 3377 | 0.020 |
Why?
|
Male | 5 | 2024 | 358719 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9269 | 0.020 |
Why?
|
Aged | 3 | 2024 | 168617 | 0.020 |
Why?
|
Transcription Factors | 1 | 2023 | 12106 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 219653 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9334 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3615 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4922 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7593 | 0.010 |
Why?
|
Female | 4 | 2024 | 390240 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18968 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18394 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58867 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29658 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 80121 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23362 | 0.010 |
Why?
|
Adult | 1 | 2024 | 219390 | 0.010 |
Why?
|